Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Specifically phosphorylates the activated forms of G protein-coupled receptors (By similarity). Additionally we are shipping G Protein-Coupled Receptor Kinase 1 Kits (9) and G Protein-Coupled Receptor Kinase 1 Proteins (5) and many more products for this protein.
Showing 10 out of 64 products:
Human Polyclonal GRK1 Primary Antibody for EIA, IHC (p) - ABIN359042
Zhao, Huang, Khani, Palczewski: Molecular forms of human rhodopsin kinase (GRK1). in The Journal of biological chemistry 1998
Show all 5 references for ABIN359042
Human Polyclonal GRK1 Primary Antibody for IHC, ELISA - ABIN1531605
Khani, Abitbol, Yamamoto, Maravic-Magovcevic, Dryja: Characterization and chromosomal localization of the gene for human rhodopsin kinase. in Genomics 1996
In the Ca(2 (show CA2 Antibodies)+)/NCS-1 (show NCS1 Antibodies).D2R (show DRD2 Antibodies) peptide complex, the C-terminal region adopts a 310 helix-turn-310 helix, whereas in the GRK1 peptide complex it forms an a-helix
Rho-kinase (show ROCK1 Antibodies) activity exhibits distinct circadian variation associated with alterations in coronary vasomotor responses and autonomic activity in VSA patients.
The selective thinning of the inner retinal layers in patients with GRM6 (show GRM6 Antibodies) mutations suggests either reduced bipolar or ganglion cell numbers or altered synaptic structure in the inner retina.
Defects in GRK1 or GRK7 (show GRK7 Antibodies) cause patients to suffer from an inability to properly deactivate rhodopsin (show RHO Antibodies) leading to problems with recovery and dark adaptation.
There are two genes that cause Oguchi disease: the G protein-coupled receptor kinase 1 gene and the S antigen (show SAG Antibodies) gene. There is evidence that Oguchi disease and retinitis pigmentosa (RP) can coexist in the same family or even in the same individual
Phosphorylation of GRK1 and GRK7 by PKA occurs in the dark, when cAMP levels in photoreceptor cells are elevated.
The disease in the Pakistani family localizes to 13q34 and is caused by a novel deletion including Exon 3 of the GRK1 gene.
G protein-coupled receptor kinase site serine cluster has a role in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation
RhoK activation in brain microvascular endothelial cells could be a cause of blood-brain barrier impairment during HIV-1 encephalitis.
A novel homozygous GRK1 mutation (p.P391H) was found in 2 Japanese siblings with Oguchi disease.
The C-terminal segment in GCAP2 (show GUCA1B Antibodies) confers target selectivity, facilitates membrane binding and provides sensitivity of the membrane localization of the protein to phosphorylation by rhodopsin kinase.
The methylation status of GRK1 is affected by nucleotide binding and by the levels of free Ca2 (show CA2 Antibodies) + via recoverin (show RCVRN Antibodies).
crystalline dimer interface was disrupted with a L166K mutation and the structure of GRK1-L166K was determined in complex with Mg(2 (show MCOLN1 Antibodies)+) . ATP to 2.5 A resolution
A novel rhodopsin-kinase-binding site within the C-terminal region of recoverin (show RCVRN Antibodies).
similar to transducin (show GNAT1 Antibodies) activation, rhodopsin (show RHO Antibodies) phosphorylation by GRK1 and high affinity arrestin-1 (show SAG Antibodies) binding only requires a rhodopsin (show RHO Antibodies) monomer
Recoverin (show RCVRN Antibodies) and rhodopsin kinase have roles in a Ca2 (show CA2 Antibodies)+-dependent feedback loop in membrane rafts from rod outer segments
an interaction surface for the recoverin (show RCVRN Antibodies) target rhodopsin kinase is constituted upon Ca2 (show CA2 Antibodies)+ binding to the non-acylated mutant
Recoverin (show RCVRN Antibodies) binds exclusively to an amphipathic peptide at the N terminus of rhodopsin kinase
Ca(2 (show CA2 Antibodies)+)-bound recoverin (show RCVRN Antibodies) is bound between rhodopsin (show RHO Antibodies) and RK in a ternary complex on rod outer segment disk membranes, thereby blocking RK interaction with rhodopsin (show RHO Antibodies) at high Ca(2 (show CA2 Antibodies)+)
key elements of rhodopsin kinase in different ligand states are involved in G protein-coupled receptor (show GPBAR1 Antibodies) kinase activation
The retinal phenotype of Grk1-/- mice is compromised by a Crb1 (show CRB1 Antibodies) rd8 mutation.
Rods and cones share the same isoforms of recoverin (show RCVRN Antibodies) and GRK1, and photoactivation also triggers a calcium decline in cones
Knockout of Unc119 (show UNC119 Antibodies) partially reversed the transport defect of GRK1 in cone photoreceptors caused by deletion of Pde6d (show PDE6D Antibodies).
rhodopsin kinase may modulate the decay of light-activated PDE (show TWIST1 Antibodies)*, which may be responsible for the quickening of response recovery in background light.
Altering the expression of GRK1 from 0.3- to 3-fold that in wild-type rods had little effect on the single photon response amplitude.
phototransduction does not play a direct role in the light-dependent dephosphorylation of GRK1.
PLCdelta3 negatively regulates RhoA (show RHOA Antibodies) expression, inhibits RhoA (show RHOA Antibodies)/Rho kinase (show ROCK2 Antibodies) signaling, and thereby promotes neurite extension.
The results of this study demonstrated a light-independent mechanism for retinal degeneration in the absence of GRK1, suggesting a second, not previously recognized role for that kinase.
Nrl (show NRL Antibodies) and Grk1 have roles in photoresponse recovery and age-related degeneration
transport of prenylated proteins, particularly GRK1 and cone phosphodiesterase, to rod and cone outer segments
Specifically phosphorylates the activated forms of G protein-coupled receptors (By similarity).
, rhodopsin kinase
, G-protein-coupled receptor kinase 1a
, G-protein coupled receptor kinase 1
, G-protein receptor kinase 1
, G protein-coupled receptpr kinase 1